Germany· DE-A57-90bd2b407a78f0a3
Taflotan Sine
A tafluprost product containing tafluprost, registered in Germany by Santen Oy. The same ATC class is registered in 16 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Tafluprost is registered in 16 of 19 countries.
Countries holding a registration under ATC S01EE05 (tafluprost), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Tafluprost · ATC S01EE05
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Tafluprost
- Manufacturer
- Santen Oy
- Country
- Germany (DE)
- ATC code
- S01EE05
- ATC class
- Tafluprost
- Defined daily dose
- 0.1 ml, AT
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tafluprost in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTAFLOTANSanten OY, Tampere
- United StatestafluprostMicro Labs Limited
- FinlandTaflotanOrifarm Oy
- United KingdomSaflutan 15micrograms/ml eye dropsSanten UK Ltd
- NetherlandsSaflutan 15 microgram/ml oogdruppels, oplossingSanten Oy
- SwitzerlandSaflutan, collyre (multidose)Santen SA
- BelgiumSaflutan 15 µg/mlSanten
- SpainSAFLUTAN 15 microgramos/ml COLIRIO EN SOLUCION EN ENVASE UNIDOSISSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Saflutan
- Belgium · Saflutan
- Bulgaria · Taflotan, Тафлотан
- Cyprus · Saflutan, Taflotan
- Czechia · Taflotan
- Denmark · Taflotan, Taflotan Sine
- Estonia · Tafdera, Taflotan
- Spain · Saflutan, Taflotan
- Finland · Taflotan, Taflotan Sine
- France · Saflutan, Tafluprost Rph Pharmaceuticals
- United Kingdom (Northern Ireland) · Saflutan, Tafluprost Brown & Burk Uk
- Greece · Saflutan, Taflotan
- Croatia · Saflutan
- Hungary · Taflotan
- Ireland · Saflutan
- Iceland · Taflotan, Taflotan Sine
- Italy · Safluround, Saflutan
- Lithuania · Taflotan
- Luxembourg · Saflutan, Tafluprost Micro Labs
- Latvia · Taflotan
- Malta · Saflutan
- Netherlands · Saflutan
- Norway · Taflotan, Taflotan Sine
- Poland · Taflotan, Taflotan Multi
- Portugal · Saflutan, Taflotan
- Romania · Saflutan
- Sweden · Taflotan, Taflotan Sine
- Slovenia · Saflutan
- Slovakia · Taflotan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1fb4615-d6ff-48a0-ab69-3859d832d4d4 GET /v1/drugs/f1fb4615-d6ff-48a0-ab69-3859d832d4d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Tafluprost",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about tafluprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.